封面
市场调查报告书
商品编码
1555029

全球医疗保健分销市场研究报告 - 2024 年至 2032 年行业分析、规模、份额、成长、趋势和预测

Global Healthcare Distribution Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: | 出版商: Value Market Research | 英文 125 Pages | 商品交期: 最快1-2个工作天内

价格

全球医疗保健分销市场需求预计将从 2023 年的 15.5 亿美元达到近 30.2 亿美元的市场规模,2024-2032 年研究期间复合年增长率为 7.69%。

医疗保健分销是指将医疗产品(包括药品、医疗器材和其他健康相关商品)从製造商交付给医疗保健提供者,并最终交付给患者。该部门对于确保医院、诊所和药房等各种医疗机构及时有效地供应医疗产品至关重要。分销过程涉及复杂的物流、仓储、库存管理和法规遵从网络,以维持产品品质和安全。医疗保健分销商在管理供应链、协调製造商、医疗保健提供者和监管机构之间发挥着不可或缺的作用,以确保产品按照行业标准运输、储存和交付。有效的分销系统对于最大限度地减少缺货、防止假冒产品和优化关键医疗用品的供应至关重要。

市场动态

慢性病的流行和人口老化推动了医疗保健分销市场的发展。医疗保健设施的成长,特别是在发展中国家,对高效分销网路产生了额外的需求。技术进步,包括实施数位供应链管理系统和自动化,正在提高分销流程的效率和准确性。此外,个人化医疗和家庭医疗保健的新兴趋势正在推动对专业分销服务的需求。医疗保健领域电子商务的兴起,包括线上药局和直接面向消费者的医疗产品,也为医疗保健分销市场的成长提供了重大机会。

此外,监管变化和提高药品可追溯性和减少假冒产品的倡议正在推动分销网络内先进追踪和监控技术的投资。随着医疗保健系统变得更加复杂,对增强整个供应链可见度和控制力的创新分销解决方案的需求预计将会增加,从而为市场参与者提供进一步的成长前景。然而,监管障碍和管理全球供应链的复杂性可能会阻碍医疗保健分销市场的成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外,这些工具还对全球医疗保健分销市场的每个细分市场进行了包容性评估。医疗保健分销行业的成长和趋势为本研究提供了整体方法。

市场区隔

医疗保健分销市场报告的这一部分提供了国家和地区层面细分市场的详细资料,从而帮助策略师确定相应产品或服务的目标人群以及即将到来的机会。

按类型

  • 製药(非处方药/维生素、仿製药、品牌/创新药)
  • 生物製药(单株抗体、疫苗、重组蛋白、血液及血液製品、其他)
  • 医疗器材分销服务

按最终用途

  • 医院药房
  • 零售药局
  • 其他

区域分析

本节涵盖区域前景,重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲医疗保健分销市场当前和未来的需求。此外,该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。医疗保健分销市场的主要参与者包括Alliance Healthcare、AmerisourceBergen Corporation、Anda Inc.、Cardinal Health Inc.、Celesio AG、CuraScript SD、Henry Schein Inc.、McKesson Corporation、Medline Industries Inc.、Morris & Dickson Co. LLC、 Owens & Minor Inc.、Patterson Companies Inc.、Pheonix Group、国药集团、Suzuken Co. Ltd.。状况等。

如果您有任何客製化要求,请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章:前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法
    • 市场研究过程
    • 市场研究方法论

第 2 章:执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章:医疗保健分布 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按类型分類的市场吸引力分析
    • 按最终用途分類的市场吸引力分析
    • 市场吸引力分析:按地区

第 4 章:价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章:全球医疗保健分销市场分析:按类型

  • 按类型概述
  • 按类型分析历史和预测数据
  • 製药(非处方药/维生素、仿製药、品牌/创新药)
  • 生物製药(单株抗体、疫苗、重组蛋白、血液及血液製品、其他)
  • 医疗器材分销服务

第 6 章:全球医疗保健分销市场分析:按最终用途分类

  • 按最终用途分类的概述
  • 按最终用途分类的历史和预测资料分析
  • 医院药房
  • 零售药局
  • 其他

第 7 章:全球医疗保健分销市场分析:按地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区按国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲按国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 8 章:医疗保健分销公司的竞争格局

  • 医疗保健分销市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 9 章:公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • Alliance Healthcare
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • AmerisourceBergen Corporation
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Anda Inc. Cardinal Health Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Celesio AG
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • CuraScript SD
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Henry Schein Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • McKesson Corporation
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Medline Industries Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Morris & Dickson Co. LLC
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Owens & Minor Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Patterson Companies Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Pheonix Group
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Sinopharm Group
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Suzuken Co. Ltd
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态

註 - 在公司概况中,财务详细资料和最新进展视情况而定,或对私人公司而言可能不包括在内

Product Code: VMR112115571

The global demand for Healthcare Distribution Market is presumed to reach the market size of nearly USD 3.02 Billion by 2032 from USD 1.55 Billion in 2023 with a CAGR of 7.69% under the study period 2024-2032.

Healthcare distribution refers to delivering medical products, including pharmaceuticals, medical devices, and other health-related goods, from manufacturers to healthcare providers and, ultimately, patients. This sector is pivotal in ensuring the timely and efficient supply of medical products across various healthcare settings, including hospitals, clinics, and pharmacies. The distribution process involves a complex network of logistics, warehousing, inventory management, and regulatory compliance to maintain product quality and safety. Healthcare distributors play an integral role in managing the supply chain, coordinating between manufacturers, healthcare providers, and regulatory bodies to ensure that products are transported, stored, and delivered by industry standards. Effective distribution systems are essential for minimizing stockouts, preventing counterfeit products, and optimizing the availability of critical medical supplies.

MARKET DYNAMICS

The propelling prevalence of chronic diseases and an aging population drive the healthcare distribution market. The growth of healthcare facilities, particularly in developing countries, creates additional demand for efficient distribution networks. Technological advances, including implementing digital supply chain management systems &automation, are improving the efficiency and accuracy of distribution processes. Furthermore, the emerging trend of personalized medicine and home healthcare is fuelling demand for specialized distribution services. The rise of e-commerce in healthcare, with online pharmacies and direct-to-consumer medical products, also presents significant opportunities for healthcare distribution market growth.

Additionally, regulatory changes and initiatives to improve drug traceability and reduce counterfeit products are driving investments in advanced tracking and monitoring technologies within the distribution network. As healthcare systems become more complex, the need for innovative distribution solutions that enhance visibility and control throughout the supply chain is expected to increase, offering further growth prospects for market players. However, regulatory hurdles and the complexities of managing global supply chains may hinder healthcare distribution market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Healthcare Distribution. The growth and trends of Healthcare Distribution industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Healthcare Distribution market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

  • Pharmaceutical (OTC Drugs/Vitamins, Generic Drugs, Brand-Name/Innovator Drugs)
  • Biopharmaceutical (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Blood And Blood Products, Other)
  • Medical Device Distribution Services

By End-use

  • Hospital Pharmacies
  • Retail Pharmacies
  • Other

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Healthcare Distribution market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Healthcare Distribution market include Alliance Healthcare, AmerisourceBergen Corporation, Anda Inc. Cardinal Health Inc., Celesio AG, CuraScript SD, Henry Schein Inc., McKesson Corporation, Medline Industries Inc., Morris & Dickson Co. LLC, Owens & Minor Inc., Patterson Companies Inc., Pheonix Group, Sinopharm Group, Suzuken Co. Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. HEALTHCARE DISTRIBUTION - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type
    • 3.7.2 Market Attractiveness Analysis By End-use
    • 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL HEALTHCARE DISTRIBUTION MARKET ANALYSIS BY TYPE

  • 5.1. Overview By Type
  • 5.2. Historical and Forecast Data Analysis By Type
  • 5.3. Pharmaceutical (OTC Drugs/Vitamins, Generic Drugs, Brand-Name/Innovator Drugs) Historic and Forecast Sales By Regions
  • 5.4. Biopharmaceutical (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Blood And Blood Products, Other) Historic and Forecast Sales By Regions
  • 5.5. Medical Device Distribution Services Historic and Forecast Sales By Regions

6. GLOBAL HEALTHCARE DISTRIBUTION MARKET ANALYSIS BY END-USE

  • 6.1. Overview By End-use
  • 6.2. Historical and Forecast Data Analysis By End-use
  • 6.3. Hospital Pharmacies Historic and Forecast Sales By Regions
  • 6.4. Retail Pharmacies Historic and Forecast Sales By Regions
  • 6.5. Other Historic and Forecast Sales By Regions

7. GLOBAL HEALTHCARE DISTRIBUTION MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.3.2 North America By Segment Sales Analysis
    • 7.3.3 North America By Country Sales Analysis
    • 7.3.4 United States Sales Analysis
    • 7.3.5 Canada Sales Analysis
    • 7.3.6 Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.4.2 Europe By Segment Sales Analysis
    • 7.4.3 Europe By Country Sales Analysis
    • 7.4.4 United Kingdom Sales Analysis
    • 7.4.5 France Sales Analysis
    • 7.4.6 Germany Sales Analysis
    • 7.4.7 Italy Sales Analysis
    • 7.4.8 Russia Sales Analysis
    • 7.4.9 Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.5.2 Asia Pacific By Segment Sales Analysis
    • 7.5.3 Asia Pacific By Country Sales Analysis
    • 7.5.4 China Sales Analysis
    • 7.5.5 India Sales Analysis
    • 7.5.6 Japan Sales Analysis
    • 7.5.7 South Korea Sales Analysis
    • 7.5.8 Australia Sales Analysis
    • 7.5.9 South East Asia Sales Analysis
    • 7.5.10 Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.6.2 Latin America By Segment Sales Analysis
    • 7.6.3 Latin America By Country Sales Analysis
    • 7.6.4 Brazil Sales Analysis
    • 7.6.5 Argentina Sales Analysis
    • 7.6.6 Peru Sales Analysis
    • 7.6.7 Chile Sales Analysis
    • 7.6.8 Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.7.2 Middle East & Africa By Segment Sales Analysis
    • 7.7.3 Middle East & Africa By Country Sales Analysis
    • 7.7.4 Saudi Arabia Sales Analysis
    • 7.7.5 UAE Sales Analysis
    • 7.7.6 Israel Sales Analysis
    • 7.7.7 South Africa Sales Analysis
    • 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE HEALTHCARE DISTRIBUTION COMPANIES

  • 8.1. Healthcare Distribution Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9. COMPANY PROFILES OF HEALTHCARE DISTRIBUTION INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. Alliance Healthcare
    • 9.3.1 Company Overview
    • 9.3.2 Company Revenue
    • 9.3.3 Products
    • 9.3.4 Recent Developments
  • 9.4. AmerisourceBergen Corporation
    • 9.4.1 Company Overview
    • 9.4.2 Company Revenue
    • 9.4.3 Products
    • 9.4.4 Recent Developments
  • 9.5. Anda Inc. Cardinal Health Inc.
    • 9.5.1 Company Overview
    • 9.5.2 Company Revenue
    • 9.5.3 Products
    • 9.5.4 Recent Developments
  • 9.6. Celesio AG
    • 9.6.1 Company Overview
    • 9.6.2 Company Revenue
    • 9.6.3 Products
    • 9.6.4 Recent Developments
  • 9.7. CuraScript SD
    • 9.7.1 Company Overview
    • 9.7.2 Company Revenue
    • 9.7.3 Products
    • 9.7.4 Recent Developments
  • 9.8. Henry Schein Inc.
    • 9.8.1 Company Overview
    • 9.8.2 Company Revenue
    • 9.8.3 Products
    • 9.8.4 Recent Developments
  • 9.9. McKesson Corporation
    • 9.9.1 Company Overview
    • 9.9.2 Company Revenue
    • 9.9.3 Products
    • 9.9.4 Recent Developments
  • 9.10. Medline Industries Inc.
    • 9.10.1 Company Overview
    • 9.10.2 Company Revenue
    • 9.10.3 Products
    • 9.10.4 Recent Developments
  • 9.11. Morris & Dickson Co. LLC
    • 9.11.1 Company Overview
    • 9.11.2 Company Revenue
    • 9.11.3 Products
    • 9.11.4 Recent Developments
  • 9.12. Owens & Minor Inc.
    • 9.12.1 Company Overview
    • 9.12.2 Company Revenue
    • 9.12.3 Products
    • 9.12.4 Recent Developments
  • 9.13. Patterson Companies Inc.
    • 9.13.1 Company Overview
    • 9.13.2 Company Revenue
    • 9.13.3 Products
    • 9.13.4 Recent Developments
  • 9.14. Pheonix Group
    • 9.14.1 Company Overview
    • 9.14.2 Company Revenue
    • 9.14.3 Products
    • 9.14.4 Recent Developments
  • 9.15. Sinopharm Group
    • 9.15.1 Company Overview
    • 9.15.2 Company Revenue
    • 9.15.3 Products
    • 9.15.4 Recent Developments
  • 9.16. Suzuken Co. Ltd
    • 9.16.1 Company Overview
    • 9.16.2 Company Revenue
    • 9.16.3 Products
    • 9.16.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Type (USD MN)
  • Pharmaceutical (OTC Drugs/Vitamins, Generic Drugs, Brand-Name/Innovator Drugs) Market Sales By Geography (USD MN)
  • Biopharmaceutical (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Blood And Blood Products, Other) Market Sales By Geography (USD MN)
  • Medical Device Distribution Services Market Sales By Geography (USD MN)
  • Analysis By End-use (USD MN)
  • Hospital Pharmacies Market Sales By Geography (USD MN)
  • Retail Pharmacies Market Sales By Geography (USD MN)
  • Other Market Sales By Geography (USD MN)
  • Global Healthcare Distribution Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Healthcare Distribution Report
  • Market Research Process
  • Market Research Methodology
  • Global Healthcare Distribution Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Type
  • Market Attractiveness Analysis By End-use
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Type (USD MN)
  • Pharmaceutical (OTC Drugs/Vitamins, Generic Drugs, Brand-Name/Innovator Drugs) Market Sales By Geography (USD MN)
  • Biopharmaceutical (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Blood And Blood Products, Other) Market Sales By Geography (USD MN)
  • Medical Device Distribution Services Market Sales By Geography (USD MN)
  • Global Market Analysis By End-use (USD MN)
  • Hospital Pharmacies Market Sales By Geography (USD MN)
  • Retail Pharmacies Market Sales By Geography (USD MN)
  • Other Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.